A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Recruiting now

Conditions studied: Relapsing Multiple Sclerosis, Multiple Sclerosis

In brief

The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting

Key facts

Study ID

NCT06433752

Run by

TG Therapeutics, Inc.

People needed

2000

Starts

2024-07-22

Expected to finish

2032-04-01

Last updated by the study team

2026-07-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed Multiple Sclerosis (MS) diagnosis.
• Participants who have not received any BRIUMVI® (ublituximab-xiiy) infusion prior to study start. Participants who have been prescribed BRIUMVI® (ublituximab-xiiy) but have not yet received their first infusion on Day 1 of 150 milligrams (mg) can be included.

You may not qualify if…

• Have received any live or live-attenuated vaccines (including for varicella-zoster virus or measles) within 4 weeks prior to first BRIUMVI® (ublituximab-xiiy) administration or any non-live vaccines within 2 weeks prior to first BRIUMVI® (ublituximab-xiiy) administration.
• Any active infection (e.g., active Hepatitis B virus [HBV])
• Concurrent participation in any interventional MS trials, or planned concurrent treatment with other Multiple Sclerosis Disease Modifying Therapy (MS DMT) during the study period.

Where it is running

• TG Therapeutics Investigational Trial Site — Huntsville, Alabama, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Mobile, Alabama, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Gilbert, Arizona, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Phoenix, Arizona, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Scottsdale, Arizona, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Fresno, California, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Newport Beach, California, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Orange, California, United States (enrolling)
• TG Therapeutics Investigational Trial Site — West Hollywood, California, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Aurora, Colorado, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Basalt, Colorado, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Colorado Springs, Colorado, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Denver, Colorado, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Fort Collins, Colorado, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Grand Junction, Colorado, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Farmington, Connecticut, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Hartford, Connecticut, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Wilmington, Delaware, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Washington D.C., District of Columbia, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Altamonte Springs, Florida, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Boca Raton, Florida, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Clearwater, Florida, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Maitland, Florida, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Miami, Florida, United States (enrolling)
• TG Therapeutics Investigational Trial Site — Birmingham, Alabama, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.